Pregnant women living with HIV are at risk

Pregnant women living with HIV are at
for TB, which can impact on maternal and
perinatal outcomes.[22] These could range
from death of the mother and the newborn, to
prematurity and low birth weight of the newborn.
[23] The Guidelines Group stressed the importance
of screening pregnant women living with HIV for
active TB using the clinical algorithm as mentioned
above. This implies the introduction of the clinical
algorithm into maternal HIV services in order
to prevent, diagnose and treat TB. The Group
concluded that evidence and experience from the
pre-HIV and HIV era suggest that IPT is safe in
pregnant women. Therefore, the Guidelines Group
strongly recommends that pregnancy should not
exclude women living with HIV from symptombased
TB screening and receiving IPT. However,
sound clinical judgement is required for decisions
such as the best time to provide IPT to pregnant
women.